Medscape

Recurrent Pericarditis in Lupus: Who’s Most at Risk?

Recurrent pericarditis occurred in one fifth of patients with systemic lupus erythematosus (SLE), with higher recurrence rates observed in younger patients and those receiving oral prednisone therapy.
Seeking Alpha

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago. Based on a successful ...
Nasdaq

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers actively enrolling patients. Activation of additional top-tier clinical sites in Europe and ...
Healio

Pericarditis recurrence in lupus more likely among patients receiving oral prednisone

Please provide your email address to receive an email when new articles are posted on . In patients with lupus, those taking prednisone or demonstrating active disease and a more recent initial ...
Nasdaq

Kiniksa Pharmaceuticals Partners with Carly Pearce to Raise Awareness for Recurrent Pericarditis in New Campaign

Kiniksa Pharmaceuticals has partnered with country music star Carly Pearce and NHL Hall-of-Famer Henrik Lundqvist to raise awareness about recurrent pericarditis, a chronic heart condition that is ...